However, it has not yet been possible to identify an optimal cut-off at which CRP would meet the target product profile proposed (sensitivity ≥90% and specificity ≥80% for differentiating bacterial from non-bacterial infections in children with non-severe, non-malarial acute fever in low-resource settings) and the ASSURED criteria [9]. This evidence concerns the gene CRP and bacterial infectious disease.